Category: Supply Chain Security

RX360 partner with ASC Associates to offer audit services to the globally recognised Rx360 audit programme.

 

RX360 partner with ASC Associates to offer audit services to the globally recognised Rx360 audit programme.

Partnership will bring global expertise in Supply Chain Security and Good Distribution Practice to RX360 members.

CAMBRIDGE, UK and PHILADELPHIA, USA, August 3rd, 2020. Rx-360, an international pharmaceutical consortium dedicated to supply chain integrity and patient safety, announces it has signed a partnership with ASC Associates Limited (ASC) a consultancy specialising in Global Supply Chain Security and Compliance. By working in partnership, Rx360 has expanded its programme of audit services available to members. ASC brings extensive knowledge and experience on Global Supply Chain Security and Good Distribution Practice compliance.

Jim Fries, CEO of Rx-360 commented, “Being able to bring choice to our membership when it comes to auditing, is a valuable tool that will continue to drive our goal of reducing industry audit burden. This expansion will also bring added focus to our mission around patient safety”.

Henry Moran, Director of ASC commented, “We are delighted and honoured to be selected as a partner for the Rx360 audit programme. With our extensive audit expertise in Supply Chain Security and Good Distribution Practice, aligned with our knowledge of all supply chain stakeholders and service providers, we look forward to working collaboratively to add value to the RX360 member and to improve global standards”.

 

About RX360

Rx-360 non-profit international consortium addresses pharmaceutical and medical device supply chain security in relation to public health concerns and patient safety. These issues affect billions of individuals around the world on a daily basis. As supply chains become more global, complex and increasingly vulnerable to adulteration and counterfeiting, Rx-360 has increased its focus on strong partnerships between pharmaceutical manufacturers and suppliers to ensure the integrity of supply chains through on-site auditing.

For more information visit RX360

About ASC

ASC Associates are a bespoke consultancy, training and auditing organisation providing services to the Life Science and Pharmaceutical supply chain. In the high-value, pharmaceutical and healthcare worlds – where threats to product safety and security are ever-increasing, we go above and beyond – dedicated to improving all aspects of supply chain logistics.  With a relentless focus on innovation, security, safety, compliance and efficacy, we take extraordinary care with attention to detail. We advise. We assess. We train. We plan. We audit. We scope. We inspect. We implement. In person.

For more information visit ASC or LinkedIn

PHARMA SECURITY WORLD 2019 ”ANTI-COUNTERFEITING, DRUG SERIALIZATION AND SUPPLY-CHAIN CONFERENCE”

On 19th/ 20th March 2019 in London, UK Corvus Global Events hosted the 2nd Annual Pharma Security World 2019 – Anti-Counterfeiting, Drug Serialization and Supply-Chain Conference, where Pharma industry experts shared various challenges faced, new strategies, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations. ASC’s Tom Cochrane shared his 35+ years’ of experience on Supply Chain Security, the important of training those within the supply chain and focused in on the EU’s Falsified Medicine Directive andDrug Supply Chain Security Act (DSCSA)Tom Cochrane ASC Associate

‘The US is driving the path with the approved in 2013. DSCSA guide for end-to-end traceability is extended over a period of 10 years, with expectations sketched throughout the supply chain. The complete supply chain is relied upon to be electronically incorporated and all hubs of traceability to be built up by November 2023. The E.U.’s Falsified Medicines Directive requires drug companies to adopt mass serialization and other anti-counterfeiting measures starting in 2019. Manufacturers who operate in the E.U. will have to add unique identification numbers to the outer packaging of all prescription drugs, and equip containers with tamperproof seals. To guide customers from illicit online drug stores that supply fake medications, the FMD requires approved legitimate Internet drug stores to show a logo distinguishing them as E.U. approved drug retailers.’

The Conference deliberations were on the following themes:

• Understanding and meeting the needs of DSCSA, EU FMD and other global regulations
• Synchrony of the Pharma Industry and professional bodies against counterfeiting
• Tackling pharmaceutical crime – initiatives at multinational, EU and national level
• IP and regulatory enforcement
• Strategies for public awareness and patient protection
• Best practices to protect your brand
• The role of the Internet in aiding the counterfeiters – How to overcome the situation?
• Common Logo initiative in the EU for online pharmacies
• Brand Protection & Securing supply chain integrity
• End to End supply chain visibility
• Developing a sustainable Serialization strategy
• Global enterprise level solutions for anti-counterfeiting
• Integration of track & trace solutions in production and supply chain
• Smart Packaging, Labeling, Artwork, Warehouse & Logistics
• Effective Authentication Technologies
• Best selection of tamper-evident features
• Developing a RMP for your supply chain to protect your Brand, Product and Patient Safety
• Measuring the Effectiveness of a Good Quality System through frequent external and internal audits
• Debating the use and implementation of serialization, barcoding, and RFID
• Serialization Data and Analytics driven approach to increase supply chain agility
• Cloud-based technology complement big data solutions in monitoring and improving supply chain processes
• The need to understand and adopt new technologies like IoT, Analytics, Block chain, Machine Learning and Artificial Intelligence
• Case study: How companies are structuring their counterfeiting efforts and departments?